Artelo Biosciences (ARTL) Non Operating Income (2017 - 2026)
Artelo Biosciences (ARTL) recorded Non Operating Income of -$269,000 in Q1 2026, compared with $7,000 a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Non Operating Income (2017 - 2026) Analysis & Trends
On a TTM basis, Artelo Biosciences' Non Operating Income came in at -$1.75 million as of Mar 31, 2026; for FY2025, it came in at -$1.48 million.
- Across earlier years, Non Operating Income came in at $282,000 in FY2024 (-56.0%), $641,000 in FY2023 (+214.2%), $204,000 in FY2022 and $10,000 in FY2021.
- Quarterly Non Operating Income has ranged from -$1.38 million in Q4 2025 to $185,000 in Q2 2023 over the past five years.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 740.9% in Q2 2023, against a decline of 93.4% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -$1.38 million (Q4 2025), -$31,000 (Q3 2025) and -$71,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | 78,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,000.00 |
| Mar 31, 2026 | -269,000.00 |
| Dec 31, 2025 | -1.38 Mn |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | 124,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | -19,000.00 |
| Nov 30, 2021 | 4,000.00 |
| Aug 31, 2021 | -4,000.00 |
API Access
Artelo Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();